Acquisition Background Former standalone dermatology and aesthetic device leader now under Allergan with proven proprietary resurfacing tech. Potential sales angle: align with Allergan’s distribution network and expand Dermalinfusion related services through existing channels.

Market Fit Integrative skin therapy approach targets hyperpigmentation, aging, and acne across in-office procedures and at-home care. Growth opportunity for bundled product offerings and recurring revenue through maintenance skincare programs.

Technology Edge Patented Dermalinfusion resurfacing technology complements advanced skincare lines. Upsell potential to clinics and medspas seeking differentiating non-invasive procedures with measurable outcomes.

Financial Signals Small to midsize revenue with acquisition history and growth capital presence; potential for scaled partnerships, white-labeling, or co-marketing arrangements with larger cosmeceutical players.

Partnership Paths Existing B2B focus and online ecosystem indicate opportunities for distribution partnerships, clinical education programs, and cross-sell of complementary devices or serums through Allergan’s network or similar enterprise buyers.